E
Sonoma Pharmaceuticals, Inc. SNOA
$3.24 -$0.03-0.92% NASDAQ
Recommendation
Prev Close
$3.24
Volume
101
Avg Vol (90D)
906,333
Market Cap
$5.51M
Dividend & Yield
--
52-Week Range
$1.75 - $6.92
P/E (TTM)
--
EPS (TTM)
-$2.20
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
11/13/2025 - GuruFocus
Sonoma Pharmaceuticals (SNOA) Achieves Recognition for Reliefacyn Hydrogel
11/13/2025 - GuruFocus
Sonoma Pharmaceuticals' Reliefacyn Advanced receives NRS Seal of Acceptance
11/13/2025 - The Fly
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
11/13/2025 - ACCESS Newswire
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Crosses Above 200-Day Moving Average - Time to Sell?
11/12/2025 - Ticker Report
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Dusseldorf
11/6/2025 - ACCESS Newswire
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results
11/4/2025 - GuruFocus
Sonoma Pharmaceuticals reports Q2 EPS (32c) vs. (59c) last year
11/4/2025 - The Fly
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results
11/4/2025 - ACCESS Newswire
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
10/14/2025 - GuruFocus
Sonoma Pharmaceuticals (SNOA) Collaborates with Medline for New Wound Cleanser Distribution
10/14/2025 - GuruFocus
Sonoma Pharmaceuticals, Medline launch HOCI wound cleanser
10/14/2025 - TipRanks Financial Blog
Sonoma Pharmaceuticals, Medline launch HOCI wound cleanser
10/14/2025 - The Fly
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
10/14/2025 - ACCESS Newswire
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and ...
10/7/2025 - GuruFocus
Sonoma Pharmaceuticals (SNOA) Expands Reach with FDA Cosmetic Registration
10/7/2025 - GuruFocus
Sonoma Pharmaceuticals lists facial spray under FDA's MoCRA
10/7/2025 - The Fly
Sonoma Pharmaceuticals registers HOCl facial spray under U.S. cosmetics law
10/7/2025 - Seeking Alpha - Healthcare
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA
10/7/2025 - ACCESS Newswire
Sonoma Pharmaceuticals Highlights Growth in Healthcare Sector
9/29/2025 - TipRanks Financial Blog
Sonoma Pharmaceuticals Enters Sales Agreement with Ladenburg
9/26/2025 - TipRanks Financial Blog
Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on ...
9/26/2025 - GuruFocus
Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
9/25/2025 - ACCESS Newswire
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Screens Well But There Might Be A Catch
9/18/2025 - Simply Wall St
National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for ...
8/26/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$16.94M
EBITDA (TTM)
-$2.98M
EBIT (TTM)
-$3.12M
Net Income (TTM)
-$3.48M
Balance Sheet
Total Assets (Q)
$13.86M
Total Debt (Q)
$535.00K
Total Liabilities (Q)
$10.07M
Book Value Per Share (Q)
$2.30
Cash Flow
Cash from Operations (TTM)
-$2.18M
Cash from Investing (TTM)
-$165.00K
Cash from Financing (TTM)
$830.00K
Net Change in Cash (TTM)
-$1.04M
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 2 and 6 (est)
Price History
Loading...
Beta
0.46
7-Day Total Return
-8.22%
30-Day Total Return
-20.63%
60-Day Total Return
-28.48%
90-Day Total Return
-12.67%
Year to Date Total Return
20.90%
1-Year Total Return
16.13%
2-Year Total Return
-1.82%
3-Year Total Return
-90.53%
5-Year Total Return
-97.63%
52-week Low
Apr 07, 2025 - $1.75
52-week High
Aug 14, 2025 - $6.92
Valuation
Market Cap
$5.51M - Nano Cap
Enterprise Value
$3.01M
Price/Sales (TTM)
0.31
Price/Book (Q)
1.41
Dividends and Shares
Shares Outstanding
1.65
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
sonomapharma.com
Phone Number
800 759 9305
Address
5445 Conestoga Court
Boulder, CO 80301
Country
United States
Year Founded
1999
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological... more
NASDAQ 11/26/2025 4:00PM Eastern Quotes delayed